Cargando…
COVID-19 editorial: mechanistic links and therapeutic challenges for metabolic diseases one year into the COVID-19 pandemic
Autores principales: | Tessier, Christopher M., Kokkinos, Alexander, Mingrone, Geltrude, Koliaki, Chrysi, Zierath, Juleen R., Mantzoros, Christos S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
W.B. Saunders
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997260/ https://www.ncbi.nlm.nih.gov/pubmed/33775648 http://dx.doi.org/10.1016/j.metabol.2021.154769 |
Ejemplares similares
-
Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19
por: Dalamaga, Maria, et al.
Publicado: (2020) -
Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stone
por: Ganjali, Shiva, et al.
Publicado: (2020) -
Visceral fat is associated to the severity of COVID-19
por: Favre, Guillaume, et al.
Publicado: (2021) -
The serum metabolome of COVID-19 patients is distinctive and predictive
por: Shi, Ding, et al.
Publicado: (2021) -
Obesity in patients with COVID-19: a systematic review and meta-analysis
por: Huang, Yi, et al.
Publicado: (2020)